Published: 30 January 2023, DOI:10.4172/2376-0249.1000872 Citation: Roobo M. (2023) PSA Test is the Use of MRI: Cost-Effective Method for Prostate Cancer Screening. Int J Clin ... author and source are credited…
analysis. Five (6.25%) out of the 81 participants analyzed heard about prostate cancer and PSA testing but none has ever undergone PSA based screening. Total PSA values ranged from
well recognized biomarker for the early diagnosis and management of prostate cancer. However, PSA test is neither disease specific nor tissue specific and test results are >70% false positive ... identify additional…
Anatomopathological screening prostate biopsy was negative. Anatomopathological screening of prostatectomy piece confirmed BPH. Serum PSA test done two weeks later. The result was 0.48 ng/mL. Conclusion: Serum PSA test
over 40 y who initiated testosterone, 33% had a pre-supplementation prostate specific antigen (PSA) test, and 12% had a PSA test 6 months after initiation. Conclusions: In a large
burden of incidence and mortality from CaP compared to White men. The prostatespecific antigen (PSA) test, a commonly used biomarker for early diagnosis and management of CaP, cannot alone accurately ... aggressiveness…
burden of incidence and mortality from CaP compared to White men. The prostatespecific antigen (PSA) test, a commonly used biomarker for early diagnosis and management of CaP, cannot alone accurately ... aggressiveness…
Prostate-Specific Antigen (PSA) was first discovered. Yet enormous uncertainty governs the effectiveness of PSA testing as well as the appropriate strategy to best detect early prostate cancer. Many groups ... existing…
elevated in prostate cancer. In 1994, the FDA approved the use of the PSA test in conjunction with digital rectral examination (DRE) to test asymptomatic pateints for prostate cancer ... with symptoms of prostatism…
prostate cancer is heavily debated because of patient management issues. Since the adoption of PSA testing for routine screening and diagnostic purposes, many men have been diagnosed through ... effect on mortality…
urination during the day and at night was over 12.5% using both biofeedback and PSA testing. Using natural herbal formula to reduce BPH instead of using prescription medications with unpredictable
prostate health index (PHI) test is a recently approved diagnostic blood test, combining free and total PSA (tPSA ... PSA isoforms ([-2]proPSA) that can reduce the number of negative prostate biopsies in PSA tested
prostate cancer screening. It begins with a detailed analysis of the prostate-specific antigen (PSA) test, the digital rectal examination (DRE), and newer biomarkers, including genetic testing and imaging techniques
aging men in our society. Prostate specific antigen (PSA) is a serine glycoprotein secreted by prostate tissues. It is a test used to diagnose prostate disease because ... hundred men aged 52-70 years were recruited for…
1980s, US Food and Drug Administration (FDA) approved the serum Prostate-Specific Antigen (PSA) test as a screening test to detect asymptomatic and earlystage prostate cancer. However, PSA
multiplex assays were developed to assist ICAP’s IF ANA testing. Aim: To identify ANA specificities in Ps and PsA using a recently developed multiplex immunoassay specifically designed ... presence of ICAP between Ps…
lack of a diagnostic test being offered that is 100% reliable. The PSA test offers an accuracy of less than 50%, so why bother with it? There is a test
pH7.5 and pH 8, as well as SEM and PSA testing. Results showed that insulin hemicelluloses microparticles having a particle size with an average of 12-17 μm and solubility
more importance aiming to early treatment with higher cure rates. The Prostate specific antigen (PSA) test is commonly used as a screening tool, as a part of the diagnostic workup ... management. Many cases undergo a…
respondents (440 with prostate disorders and 60 as controls) were screened using venous blood PSA tests. Data on socio-demographics and potential risk factors were collected through face-to-face
cancer, discussing its effectiveness in conjunction with other diagnostic methods like prostate-specific antigen (PSA) testing and magnetic resonance imaging (MRI). We also address the limitations of the DRE, including
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.